QIAGEN N.V. (QGEN) Form 6-K — Oct 23, 2026
QIAGEN announced on October 21, 2026 a Business Combination Agreement under which Crown NL Bidco B.V., a vehicle backed by EQT, will launch a full cash tender offer for all QIAGEN ordinary shares at EUR 46.50 per share. Both the Managing Board and Supervisory Board unanimously approved and will recommend the offer, supported by fairness opinions from Moelis, Goldman Sachs, and Perella Weinberg. The deal is fully financed, with EUR 5,966.9 million in binding equity commitments plus committed debt financing, and closing is not conditioned on financing.
Key figures
- Gross Proceeds
- EUR 5,966.9 million equity financing committed
- Offering Price
- 46.5
- Shares Outstanding
- 206496521
- Offer currency
- EUR
- Acceptance threshold
- 50%+1 of Outstanding Capital
- Squeeze out threshold
- 95%
- Acceptance period weeks
- 10
- Dax market out threshold
- below 18,978.32 points (25% decline)
- Sp500 market out threshold
- below 5,784.43 points (25% decline)
- Additional acceptance period weeks
- 2
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.